The clinical director of the Breast Oncology Program at the University of Michigan sees great promise in the FDA’s plans to regulate molecular diagnostic testing in cancer care, and called on third-party payers to support bringing rigor to the field by reimbursing those tests that pass regulatory muster.
Sam Donaldson, award-winning 44-year ABC News veteran and melanoma survivor, will be the keynote speaker at the 11th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® on March 7. The Continuing Medical Education-certified conference, sponsored by Physicians’ Education Resource®, LLC (PER®), will take place at the InterContinental Miami Hotel in Miami, Fla.
Measuring a person’s subtle, unconscious responses during conversation typically requires hooking them up to wires and telling them not to move – circumstances that are less than conversational – but now three researchers, including an HRA – Healthcare Research & Analytics vice president known for her innovative ideas, will report the findings from a study extending these experiments to real-world situations.
A growing number of oncologists are following standard, scientifically proven treatment algorithms called clinical pathways, tools designed to help oncologists make decisions based on best practices rather than habit or other factors. While the pathways leave room for individualized care, they also threaten to leave some cancer drugs by the wayside in the future, according to a new study from HRA – Healthcare Research & Analytics, a leading consultative healthcare market research practice.
Pharmacy Times, an industry-leading media resource providing practical information to pharmacists, today announced a strategic collaboration with the Pharmacy Podcast Show, an audio blog for pharmacy owners and management teams, to strengthen dialogue and spur innovation around key topics regarding the pharmacy profession, healthcare, and pharmacy business. Pharmacy Podcast creator and host Todd S. Eury will work with Pharmacy Times to create future content and episodes of the podcast that will be integrated into the blog section of the Pharmacy Times website.
When award-winning journalist Joan Lunden was first diagnosed with triple-negative breast cancer, she opted to embrace anatypical treatment regimen—chemotherapy first, then surgery, rather than the reverse, she revealed in an interview with CURE™, the largest cancer magazine in the nation.
Rare Disease Communications (RDC), a growing healthcare communications and media company, today announced the debut of a new print publication, Rare Disease Report™, that will deliver crucial information directly to physicians to assist in diagnosing and treating patients suffering from rare diseases.